Discover 630 paid clinical trials in Charlotte, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Charlotte offers many opportunities to participate in clinical research focused on various conditions, including cancer, lymphoma, heart disease, and cystic fibrosis. The city’s medical research institutions are recruiting both healthy volunteers interested in paid trials, as well as individuals with specific health conditions.
Filter
2
Filter results
Results: 630
Active & ResponsiveNew
A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza
for
Influenza
Location: Charlotte NC, Monroe NC, Salisbury NC, Spartanburg SC,
Sponsor: Cidara Therapeutics Inc.
Sex: All
Age: 12+
Code: NCT07159763
Phase3, Recruiting
Active & ResponsiveNew
Unity VCS: A Comparison Study Evaluating Corneal Clarity and Thickness
for
Cataract
Location: Matthews NC
Sponsor: Metrolina Eye Associates, PLLC
Sex: All
Age: 18+
Code: NCT07222150
Recruiting
Active & Responsive
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma
for
Non-Hodgkin Lymphoma
Location: Charlotte NC, Tampa FL, Chicago IL, Houston TX,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT05169515
Phase1, Recruiting
Active & Responsive
Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants with Rheumatoid Arthritis with Inadequate Response or Intolerance to a DMARD Starting a New BDMARD or TsDMARD Treatment +/- CsDMARD
Location: Charlotte NC, Durham NC, Augusta GA, Wilmington NC,
Sponsor: Procyrion
Sex: All
Age: 21+
Code: NCT05677100
Recruiting
Active & Responsive
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
for
Metastatic Breast Cancer
Location: Charlotte NC, Matthews NC, Huntersville NC, Concord NC,
Sponsor: American Society of Clinical Oncology
Sex: All
Age: 65+
Code: NCT06377852
Phase3, Recruiting
Active & Responsive
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Charlotte NC, Goldsboro NC, Charlottesville VA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136559
Phase3, Recruiting
Active & Responsive
Esprit BTK Post-Approval Study
for
Chronic Limb-Threatening Ischemia
Location: Charlotte NC, Johnson City TN, Atlanta GA,
Sponsor: Abbott Medical Devices
Sex: All
Age: 18+
Code: NCT06656364
Recruiting
Active & Responsive
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)